Explaining the Release Mechanism of Ritonavir/PVPVA Amorphous Solid Dispersions.
Ontology highlight
ABSTRACT: In amorphous solid dispersions (ASDs), an active pharmaceutical ingredient (API) is dissolved on a molecular level in a polymeric matrix. The API is expected to be released from the ASD upon dissolution in aqueous media. However, a series of earlier works observed a drastic collapse of the API release for ASDs with high drug loads (DLs) compared to those with low DLs. This work provides a thermodynamic analysis of the release mechanism of ASDs composed of ritonavir (RIT) and poly(vinylpyrrolidone-co-vinyl acetate) (PVPVA). The observed release behavior is, for the first time, explained based on the quantitative thermodynamic phase diagram predicted by PC-SAFT. Both liquid-liquid phase separation in the dissolution medium, as well as amorphous phase separation in the ASD, could be linked ba
SUBMITTER: Krummnow A
PROVIDER: S-EPMC9505701 | biostudies-literature | 2022 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA